NASDAQ
MaxCyte, Inc. (MXCT) has a revenue compound annual growth rate of 4.76% over 5 years and 13.52% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.